The present study aimed to assess the pharmacological activity of the PDE inhibitor, GRMS-55, and elucidate its mechanisms of action in ConA-induced hepatitis in mice by correlating the compound concentration–effect data using a PK/PD/disease progression model designed for this purpose. Here, ALDH7A1 is linked to Hepatitis.